Pfizer (PFE) Stock: Pharma Giant Battles Novo Nordisk Over $9 Billion Metsera Deal

TLDR Novo Nordisk launched an unsolicited $9 billion offer for Metsera, trumping Pfizer’s existing $7.3 billion acquisition agreement. Pfizer condemned the move as reckless and pledged to pursue legal action to protect its deal with the weight-loss drug developer. The obesity treatment market is expected to reach $72 billion in 2025 and climb to $139 [...]

The post Pfizer (PFE) Stock: Pharma Giant Battles Novo Nordisk Over $9 Billion Metsera Deal appeared first on Blockonomi.